Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3W Partners is a specialist private equity firm that focuses on mid-market investment opportunities in the healthcare, consumer, and advanced manufacturing sectors, primarily in Greater China and globally. The firm employs a thematic-driven investment strategy, leveraging its deep industry expertise and extensive network to partner with management teams and drive value creation. In the healthcare space, 3W Partners has been an active investor in biotechnology, medical devices, and healthcare services, supporting companies through various stages of growth. Notable investments include leading roles in funding rounds for prominent biotech firms such as I-Mab Biopharma and CStone Pharmaceuticals. The firm is led by experienced professionals with backgrounds in global investment banking and private equity, including former executives from Goldman Sachs and TPG. 3W Partners operates with a philosophy centered on creating value for all stakeholders, often referred to as their Win-Win-Win approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3W Partners.